Adverse Events As A Potential Clinical Marker Of Antitumor Efficacy In Ovarian Cancer Patients Treated With Poly Adp-Ribose Polymerase (Parp) Inhibitor
GYNECOLOGIC ONCOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
GYNECOLOGIC ONCOLOGY(2021)